Generate a tailored SOP for Dr. Olaf Klungel. Improve your application with a focused, well-structured draft.
Olaf Klungel is a Professor and Academic Director specializing in Pharmacoepidemiologic Methods at Utrecht University. As head of the division of Pharmacoepidemiology & Clinical Pharmacology, he has substantial expertise in the development, improvement, and evaluation of innovative methods in observational drug research. His main focus is on applications in the post-registration phase of drug development. He holds an adjunct professorship in Pharmacoepidemiology at the University of Southern Denmark in Odense and is a trained pharmacist and epidemiologist. Klungel has represented his division in various European networks, including being part of the European Network of Centres for Pharmacoepidemiology and Pharmacovigilance (ENCePP) and serving on the EU2P steering committee. His extensive research contributions include over 350 peer-reviewed papers and reports, addressing significant findings such as the impact of genetic variants on the renin-angiotensin system regarding the risk of type 2 diabetes and myocardial infarction. His recent research indicates increased risks of autoimmune diseases related to the use of statins. In addition to his research, Klungel is actively involved in teaching pharmacoepidemiology and pharmacotherapy to medical pharmacy students.
Utrecht University • Utrecht, Netherlands
Leads the division of Pharmacoepidemiology & Clinical Pharmacology, focusing on innovative methods in observational drug research.
University of Southern Denmark • Odense, Denmark
Teaches and researches in the field of Pharmacoepidemiology.
Department of Psychology